• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Neurotech International

Neurotech International

ASX:NTI

  • Home
  • Corporate
    • Board and Management
    • Corporate Directory
    • Corporate Governance
    • Corporate Videos
  • Development Programs
    • Biopharmaceutical Trials
    • Group Strategy and Target Markets
    • NTI164
    • Clinical Trials
    • Pathways to Commercialisation
  • Investors
    • Investor Dashboard
    • ASX Announcements
    • Investor Conference Calls  
    • Company Reports
    • Presentations
    • Research
    • News & Media
    • Fact Sheets
    • Analyst Reports
    • Right to Receive Documents
  • Contact

Corporate
Governance

The Board of Neurotech sets a high standard in fulfilling its obligations and responsibilities to stakeholders. As such the Board has established a set of corporate governance practices and procedures in order to carry out their fiduciary duties and obligations. These guidelines may be subject to modification as the Board deems appropriate in the best interests of Neurotech or as required by applicable laws and regulations.

Corporate Governance Statement
Corporate Governance Plan
Whistleblower Policy
Constitution

Footer

Suite 102 / Level 1, 55 Collins Street
Melbourne VIC 3000
Australia

moc.l1761102911anoit1761102911anret1761102911nihce1761102911torue1761102911n@ofn1761102911i1761102911

+61 (3) 9498 3132

Subscribe to our latest announcements

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.

Copyright © 2025 Neurotech International • Site by White Noise Communications

Download prospectus